These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1733472)

  • 1. [The value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and relapse diagnosis of colorectal tumors].
    Barzen G; Zwicker C; Neumann K; Löhde E; Raakow R; Böse-Landgraf W; Richter W; Hierholzer J; Langer M; Felix R
    Rofo; 1992 Jan; 156(1):3-10. PubMed ID: 1733472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value].
    Barzen G; Martini I; Schulz W; Löhde E; Böse-Landgraf J; Richter W; Langer M; Felix R
    Med Klin (Munich); 1992 Aug; 87(8):395-402. PubMed ID: 1406470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
    Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
    Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Typical findings and erroneous findings in SPECT-radioimmunoscintigraphy using 99mTc-labeled CEA antibodies in colorectal tumors].
    Barzen G; Felix R
    Aktuelle Radiol; 1992 Jul; 2(4):212-9. PubMed ID: 1504120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
    Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunoscintigraphy of colorectal tumors: state of the art (2)].
    Barzen G; Felix R
    Aktuelle Radiol; 1992 Sep; 2(5):262-70. PubMed ID: 1420384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
    Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
    Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
    Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
    Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
    J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
    Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
    J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer.
    Lunniss PJ; Skinner S; Britton KE; Granowska M; Morris G; Northover JM
    Br J Surg; 1999 Feb; 86(2):244-9. PubMed ID: 10100796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging.
    Moffat FL; Gulec SA; Serafini AN; Sfakianakis GN; Pop R; Robinson DS; Franceschi D; Boggs J; Livingstone AS
    Cancer Invest; 1999; 17(5):322-34. PubMed ID: 10370360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma].
    Muxí Pradas MA; Pons Pons F; Huguet Planella M; Novell Capilla F; García-Romero RH; Trias Folch M
    Med Clin (Barc); 1996 Nov; 107(16):601-7. PubMed ID: 9064391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
    Bischof-Delaloye A; Delaloye B; Buchegger F; Gilgien W; Studer A; Curchod S; Givel JC; Mosimann F; Pettavel J; Mach JP
    J Nucl Med; 1989 Oct; 30(10):1646-56. PubMed ID: 2795205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
    Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals.
    Obradovic V; Artiko V; Petrovic M; Lausevic Z; Stojkovic M; Sobic-Saranovic D; Petrovic N; Vlajkovic M; Krivokapic Z
    Neoplasma; 2006; 53(5):444-9. PubMed ID: 17013541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
    Oliva JP; Pimentel G; Borrón M; Peralta R; Ortiz R; Oliver B; Díaz N; Sánchez I; Vázquez AM; Baum RP
    Rev Esp Med Nucl; 2001 Jun; 20(4):282-8. PubMed ID: 11940415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study].
    Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH
    Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The place of radioimmunoscintigraphy in the diagnosis and follow-up of ovarian cancer in comparison with computed tomography and second-look surgery].
    Barzen G; Friedmann W; Richter W; Schönegg W; Riess H; Eichstädt H; Lichtenegger W; Felix R
    Nuklearmedizin; 1992 Feb; 31(1):16-23. PubMed ID: 1561116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.